Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator
Clinical trial NCT01742299 · COMPLETED
Trial details
- NCT number
- NCT01742299
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-26
- Primary completion
- 2026-04-20
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.